Johnson & Johnson (JNJ)
XETR
Real-time Data
07:00 AM
Day's Range
228.3052 wk Range
146.98Overview - JNJ - Johnson & Johnson
Key Statistics
Valuation
Enterprise Value
503.28B
P/E (Trailing)
‪31.44‬
PEG Ratio
‪-275.07‬
Price / Sales (TTM)
‪5.72‬
Price / Book
‪7.63‬
EV / EBITDA
‪16.89‬
Profitability
Gross Margin
‪68.19%‬
Profit Margin
‪21.48%‬
Operating Margin
‪29.19%‬
Return on Assets
‪8.59%‬
Return on Equity
‪25.74%‬
Ownership
Shares Outstanding
2.40B
Float
2.40B
Held by Insiders
‪0.05%‬
Held by Institutions
‪76.90%‬
Price stats
Beta
‪0.23‬
50-Day Avg
‪221.90‬
200-Day Avg
‪200.58‬
Dividends
Payout Ratio
‪60.79%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - JNJ - Johnson & Johnson
Peers - JNJ - Johnson & Johnson
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XETR.
Profile Summary - JNJ - Johnson & Johnson
About
Johnson & Johnson is a holding company engaged in the research, development, manufacture, and sale of healthcare products worldwide. It operates through two primary segments: Innovative Medicine, which focuses on pharmaceuticals including treatments for immunology, oncology, infectious diseases, neuroscience,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
